Melissa Murray, Partner, and Saladin Aljurf, Counsel, have contributed the UAE chapter to the latest publication of the Life Science Review
Written By
Partner
United Arab Emirates
I am the head of the Intellectual Property Group for the Middle East offices and a partner in the International Commercial Group. I've practised in the UAE since 2006 and I'm ranked in IP Stars, Chambers & Partners, Legal 500 and Who's Who Legal for my commercial and intellectual property experience.
Melissa Murray, Partner, and Saladin Aljurf, Counsel, have contributed the UAE chapter to the latest publication of the Life Science Review. The UAE chapter covers:
- the Regulatory Regime;
- Pricing & Reimbursement;
- Administrative & Judicial Remedies;
- Financial Relationships with Prescribers & Players;
- Special Liability or Compensation Systems;
- Transactional & Competition Issues; and
- Current Developments.
Saladin Aljurf, Counsel, says: "The continuously evolving landscape of UAE law in life sciences and other sectors reflects its desire to become a world player in these fields in the foreseeable future."
As part of its vision to be one of the most innovative countries in the world, Dubai Biotechnology and Research Park (DuBiotech), a free zone founded in 2005, supported the growth and development of the life sciences field in the region. According to a report by BMI, the life science sector is expected to reach AED 69.37bn (USD18.90bn) by 2019, representing 37% growth from 2014 (AED50.79bn/USD13.83bn).
You can view the UAE chapter of the Life Science Review here.
